Comparison of the Latin America Regulation Landscape and International Reference Health Authorities to Hasten Drug Registration and Clinical Research Applications

INTRODUCTION: Promptly providing new drugs to fulfill unmet medical needs requires changes in drug development and registration processes. Health Authorities (HAs) considered as reference due to their experience and acknowledgement (Food and Drug Administration [FDA] among others) already consider i...

Descripción completa

Detalles Bibliográficos
Autores principales: Argotti, Urimara, Leyens, Lada, Lisbona, Carlos, López, Pilar, Alonso-Orgaz, Sergio, Nevado, Angel, Cozzi, Virginia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579156/
https://www.ncbi.nlm.nih.gov/pubmed/37682461
http://dx.doi.org/10.1007/s43441-023-00565-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579156/
https://www.ncbi.nlm.nih.gov/pubmed/37682461
http://dx.doi.org/10.1007/s43441-023-00565-7

Ejemplares similares